A citation-based method for searching scientific literature

Isabel Ortuño-Lizarán, Xavier Sánchez-Sáez, Pedro Lax, Geidy E Serrano, Thomas G Beach, Charles H Adler, Nicolás Cuenca. Ann Neurol 2020
Times Cited: 20







List of co-cited articles
176 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.
Isabel Ortuño-Lizarán, Thomas G Beach, Geidy E Serrano, Douglas G Walker, Charles H Adler, Nicolás Cuenca. Mov Disord 2018
66
50

Decreased dopamine in the retinas of patients with Parkinson's disease.
C Harnois, T Di Paolo. Invest Ophthalmol Vis Sci 1990
247
35

Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkers.
Li Guo, Eduardo M Normando, Parth Arvind Shah, Lies De Groef, M Francesca Cordeiro. Mov Disord 2018
37
30

Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern?
C La Morgia, P Barboni, G Rizzo, M Carbonelli, G Savini, C Scaglione, S Capellari, S Bonazza, M P Giannoccaro, G Calandra-Buonaura,[...]. Eur J Neurol 2013
78
30

α-synuclein in the inner retina in parkinson disease.
Ivan Bodis-Wollner, Piotr B Kozlowski, Sofya Glazman, Shahnaz Miri. Ann Neurol 2014
100
30

Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease.
Isabel Ortuño-Lizarán, Gema Esquiva, Thomas G Beach, Geidy E Serrano, Charles H Adler, Pedro Lax, Nicolás Cuenca. Acta Neuropathol Commun 2018
30
30

Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
Josie-Anne Bertrand, Christophe Bedetti, Ronald B Postuma, Oury Monchi, Daphné Génier Marchand, Thomas Jubault, Jean-François Gagnon. Mov Disord 2012
56
25

Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.
Thomas G Beach, Jeremiah Carew, Geidy Serrano, Charles H Adler, Holly A Shill, Lucia I Sue, Marwan N Sabbagh, Haruhiko Akiyama, Nicolás Cuenca. Neurosci Lett 2014
78
25

Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
Najiba Mammadova, Corey M Summers, Robyn D Kokemuller, Qing He, Shaowei Ding, Thierry Baron, Chenxu Yu, Rudy J Valentine, Donald S Sakaguchi, Anumantha G Kanthasamy,[...]. Neurobiol Dis 2019
22
25

Visual dysfunction in Parkinson disease without dementia.
E Y Uc, M Rizzo, S W Anderson, S Qian, R L Rodnitzky, J D Dawson. Neurology 2005
192
25

Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.
V Polo, M Satue, M J Rodrigo, S Otin, R Alarcia, M P Bambo, M I Fuertes, J M Larrosa, L E Pablo, E Garcia-Martin. BMJ Open 2016
41
25

Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss.
Marilita M Moschos, Georgios Tagaris, Ioannis Markopoulos, Ioannis Margetis, Stylianos Tsapakis, Menelaos Kanakis, Chrysanthi Koutsandrea. Eur J Ophthalmol 2011
111
25


Characterization of Retinal Microvascular and Choroidal Structural Changes in Parkinson Disease.
Cason B Robbins, Atalie C Thompson, Paramjit K Bhullar, Hui Yan Koo, Rupesh Agrawal, Srinath Soundararajan, Stephen P Yoon, Bryce W Polascik, Burton L Scott, Dilraj S Grewal,[...]. JAMA Ophthalmol 2021
27
25

The retina as a window to the brain-from eye research to CNS disorders.
Anat London, Inbal Benhar, Michal Schwartz. Nat Rev Neurol 2013
465
25

The retina in Parkinson's disease.
Neil K Archibald, Michael P Clarke, Urs P Mosimann, David J Burn. Brain 2009
221
25

Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.
Jee-Young Lee, Jae Min Kim, Jeeyun Ahn, Han-Joon Kim, Beom S Jeon, Tae Wan Kim. Mov Disord 2014
72
20

Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked.
Merel S Ekker, Sabine Janssen, Klaus Seppi, Werner Poewe, Nienke M de Vries, Thomas Theelen, Jorik Nonnekes, Bastiaan R Bloem. Parkinsonism Relat Disord 2017
53
20

Visual dysfunction in Parkinson's disease.
Rimona S Weil, Anette E Schrag, Jason D Warren, Sebastian J Crutch, Andrew J Lees, Huw R Morris. Brain 2016
179
20

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
20

Optical coherence tomography in parkinsonian syndromes.
Philipp Albrecht, Ann-Kristin Müller, Martin Südmeyer, Stefano Ferrea, Marius Ringelstein, Eva Cohn, Orhan Aktas, Thomas Dietlein, Alexandra Lappas, Andreas Foerster,[...]. PLoS One 2012
116
20

Retinal changes in Parkinson's disease and glaucoma.
Juliane Matlach, Martin Wagner, Uwe Malzahn, Irene Schmidtmann, Frank Steigerwald, Thomas Musacchio, Jens Volkmann, Franz Grehn, Winfried Göbel, Stephan Klebe. Parkinsonism Relat Disord 2018
21
20

Foveal vision is impaired in Parkinson's disease.
Ivan Bodis-Wollner. Parkinsonism Relat Disord 2013
46
20

Retinal α-synuclein deposits in Parkinson's disease patients and animal models.
Lien Veys, Marjan Vandenabeele, Isabel Ortuño-Lizarán, Veerle Baekelandt, Nicolás Cuenca, Lieve Moons, Lies De Groef. Acta Neuropathol 2019
41
20

Visual symptoms in Parkinson's disease and Parkinson's disease dementia.
Neil K Archibald, Mike P Clarke, Urs P Mosimann, David J Burn. Mov Disord 2011
119
20

Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease.
Christopher R Adam, Eric Shrier, Yin Ding, Sofya Glazman, Ivan Bodis-Wollner. J Neuroophthalmol 2013
61
20

Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
M F Silva, P Faria, F S Regateiro, V Forjaz, C Januário, A Freire, M Castelo-Branco. Brain 2005
91
20

MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
20

Abnormalities in color vision and contrast sensitivity in Parkinson's disease.
M J Price, R G Feldman, D Adelberg, H Kayne. Neurology 1992
174
20

Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD).
Barbara Nowacka, Wojciech Lubiński, Krystyna Honczarenko, Andrzej Potemkowski, Krzysztof Safranow. Doc Ophthalmol 2015
26
20

α-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells.
Elena Marrocco, Alessia Indrieri, Federica Esposito, Valeria Tarallo, Anna Carboncino, Filomena Grazia Alvino, Sandro De Falco, Brunella Franco, Maria De Risi, Elvira De Leonibus. Sci Rep 2020
8
50

Retinal nerve fiber layer thinning in Parkinson disease.
Rivka Inzelberg, Jose Antonio Ramirez, Puiu Nisipeanu, Avinoam Ophir. Vision Res 2004
224
20

Retina thickness as a marker of neurodegeneration in prodromal lewy body disease.
Jee-Young Lee, Jeeyun Ahn, Sohee Oh, Joo Young Shin, Yu Kyeong Kim, Hyunwoo Nam, Beomseok Jeon. Mov Disord 2020
13
30

Retinal Microvascular Impairment in the Early Stages of Parkinson's Disease.
William Robert Kwapong, Hua Ye, Chenlei Peng, Xiran Zhuang, Jianhua Wang, Meixiao Shen, Fan Lu. Invest Ophthalmol Vis Sci 2018
47
20

CHARACTERIZATION BY FRACTAL DIMENSION ANALYSIS OF THE RETINAL CAPILLARY NETWORK IN PARKINSON DISEASE.
Ce Shi, Yihong Chen, William Robert Kwapong, Qiaowen Tong, Senxiang Wu, Yuheng Zhou, Hanpei Miao, Meixiao Shen, Hua Ye. Retina 2020
20
20

Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity.
Elena Garcia-Martin, Diego Rodriguez-Mena, Maria Satue, Carmen Almarcegui, Isabel Dolz, Raquel Alarcia, Maria Seral, Vicente Polo, Jose M Larrosa, Luis E Pablo. Invest Ophthalmol Vis Sci 2014
67
20

Development of a prediction formula of Parkinson disease severity by optical coherence tomography.
Beatriz Jiménez, Francisco J Ascaso, José A Cristóbal, Javier López del Val. Mov Disord 2014
56
20

Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography.
Grant D Aaker, Jane S Myung, Joshua R Ehrlich, Mujtaba Mohammed, Claire Henchcliffe, Szilárd Kiss. Clin Ophthalmol 2010
86
15

Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease.
Nicolás Cuenca, María-Trinidad Herrero, Antonia Angulo, Emilio de Juan, Gema C Martínez-Navarrete, Salvador López, Carlos Barcia, José Martín-Nieto. J Comp Neurol 2005
42
15


Oculo-Visual Dysfunction in Parkinson's Disease.
R A Armstrong. J Parkinsons Dis 2015
57
15

Interocular asymmetry of foveal thickness in Parkinson disease.
Eric M Shrier, Christopher R Adam, Brian Spund, Sofya Glazman, Ivan Bodis-Wollner. J Ophthalmol 2012
51
15

A rat model of Parkinsonism shows depletion of dopamine in the retina.
Oliver Biehlmaier, Mesbah Alam, Werner J Schmidt. Neurochem Int 2007
28
15

Optical coherence tomography findings in Parkinson's disease.
Turkoglu Sule Aydin, Dogan Umit, Ogun Muhammed Nur, Ulas Fatih, Keles Asena, Ozturk Yavas Nefise, Yildiz Serpil. Kaohsiung J Med Sci 2018
14
21

Visual dysfunction in patients with Parkinson's disease and essential tremor.
Ivanka Štenc Bradvica, Mario Bradvica, Suzana Matić, Patricia Reisz-Majić. Neurol Sci 2015
14
21

Decreased color discrimination and contrast sensitivity in Parkinson's disease.
V Pieri, N J Diederich, R Raman, C G Goetz. J Neurol Sci 2000
103
15

A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease.
Shahnaz Miri, Sofya Glazman, Leland Mylin, Ivan Bodis-Wollner. Parkinsonism Relat Disord 2016
29
15

Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina.
Julián Esteve-Rudd, Laura Fernández-Sánchez, Pedro Lax, Emilio De Juan, José Martín-Nieto, Nicolás Cuenca. Neurobiol Dis 2011
35
15

Contralateral retinal dopamine decrease and melatonin increase in progression of hemiparkinsonium rat.
Tao Meng, Zhi-Hong Zheng, Ting-Ting Liu, Ling Lin. Neurochem Res 2012
12
25

The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.
Eduardo Maria Normando, Benjamin Michael Davis, Lies De Groef, Shereen Nizari, Lisa A Turner, Nivedita Ravindran, Milena Pahlitzsch, Jonathan Brenton, Giulia Malaguarnera, Li Guo,[...]. Acta Neuropathol Commun 2016
59
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.